Quick answer
Sometimes. ACA plans must cover obesity screening and intensive behavioral counseling at no cost for adults and children who qualify, and many plans cover bariatric surgery when it’s medically necessary. Commercial weight-loss programs and GLP-1 drugs like Wegovy and Zepbound are less consistently covered. Medicare started a temporary program in July 2026 that covers these drugs for obesity for $50 a month for people who qualify.
Key takeaways
- Obesity counseling recommended by the USPSTF is free on ACA plans.
- Many plans cover bariatric surgery with prior approval and requirements like a supervised diet.
- Only 19% of large employers covered GLP-1 drugs for weight loss in 2025, though 43% of the largest did. See does insurance cover Wegovy, Zepbound or Ozempic.
- Medicare’s GLP-1 bridge program charges a $50 monthly copay for eligible people, starting July 1, 2026.
- Commercial diet programs are rarely covered, but HSA or FSA money can pay for some when a doctor treats a diagnosed disease.
On this page
What’s usually covered
| Treatment | Usually covered? |
|---|---|
| Obesity screening and behavioral counseling | Yes, at no cost on ACA plans |
| Nutrition counseling for conditions like diabetes | Often |
| GLP-1 drugs for weight loss | Varies; many plans exclude them or require prior approval |
| Bariatric surgery | Often, when medically necessary |
| Commercial diet programs and gym memberships | Rarely |
Children 6 and older with obesity are covered for intensive behavioral programs too; see health insurance for children.
GLP-1 drugs
Coverage for Wegovy, Zepbound and similar drugs depends on your plan and the reason they’re prescribed. Plans are more likely to cover them for type 2 diabetes, heart disease risk or sleep apnea than for weight loss alone. KFF found 19% of employers with 200 or more workers covered GLP-1s for weight loss in 2025, rising to 43% of employers with 5,000 or more workers. Some insurers cited these drugs when raising 2027 premiums.
Medicare’s GLP-1 bridge program
Starting July 1, 2026, Medicare covers Wegovy, Zepbound (KwikPen) and Foundayo for obesity with a $50 monthly copay for people 18 and older who meet BMI and health criteria, such as a BMI of 35 or higher. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease get these drugs through their regular drug plans instead. The program is temporary.
Bariatric surgery
Many plans, and Medicare, cover weight-loss surgery for people with severe obesity, usually a BMI of 35 or higher with a related condition, or 40 and higher. Expect requirements like a documented diet attempt and a psychological evaluation. Use in-network surgeons and facilities to avoid big bills; see what to do about out-of-network costs.
Choosing a plan
If weight-loss treatment matters to you, check each plan’s drug list and medical policies before you enroll. Compare plan levels and insurers; see comparing health insurance. ACA plans can’t charge more or deny you because of your weight or related conditions; see getting health insurance with pre-existing conditions. Going without coverage leaves you paying full price for related care; see the worst that can happen if you get sick without health insurance.
Compare plans’ drug coverage in your area: see quotes by ZIP code.
Frequently asked questions
Does insurance cover Wegovy or Zepbound for weight loss?
Some plans do, often with prior approval. Many exclude drugs used only for weight loss. Medicare covers them for eligible people through a temporary $50-a-month program that started in July 2026.
Will my health insurance pay for a weight-loss program like a diet plan?
Rarely. ACA plans do cover obesity counseling at no cost for people who qualify.
Can I use my HSA for weight-loss costs?
Only when the program treats a specific disease diagnosed by a doctor, like obesity; general wellness programs don’t qualify.
Sources
This article is general information, not medical advice. Talk with your doctor about treatment options. Last reviewed September 2026.